OA12399A - Sodium salts of 5-'4-'2-(N-methyl-N-(2-pyridyl)ethoxyÜthiazolidine-2,4-dione. - Google Patents

Sodium salts of 5-'4-'2-(N-methyl-N-(2-pyridyl)ethoxyÜthiazolidine-2,4-dione. Download PDF

Info

Publication number
OA12399A
OA12399A OA1200300090A OA1200300090A OA12399A OA 12399 A OA12399 A OA 12399A OA 1200300090 A OA1200300090 A OA 1200300090A OA 1200300090 A OA1200300090 A OA 1200300090A OA 12399 A OA12399 A OA 12399A
Authority
OA
OAPI
Prior art keywords
sait
pyridyl
methyl
dione
ethoxy
Prior art date
Application number
OA1200300090A
Other languages
English (en)
Inventor
Gbandrew Simon Craig
Michael Millan
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of OA12399A publication Critical patent/OA12399A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
OA1200300090A 2000-09-29 2001-09-28 Sodium salts of 5-'4-'2-(N-methyl-N-(2-pyridyl)ethoxyÜthiazolidine-2,4-dione. OA12399A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0023971.5A GB0023971D0 (en) 2000-09-29 2000-09-29 Novel pharmaceutical

Publications (1)

Publication Number Publication Date
OA12399A true OA12399A (en) 2004-09-06

Family

ID=9900428

Family Applications (1)

Application Number Title Priority Date Filing Date
OA1200300090A OA12399A (en) 2000-09-29 2001-09-28 Sodium salts of 5-'4-'2-(N-methyl-N-(2-pyridyl)ethoxyÜthiazolidine-2,4-dione.

Country Status (27)

Country Link
US (4) US20040014752A1 (fr)
EP (2) EP1332142A1 (fr)
JP (1) JP2004509959A (fr)
KR (1) KR100917953B1 (fr)
CN (4) CN101125852A (fr)
AP (1) AP1738A (fr)
AU (2) AU2001292028B2 (fr)
BG (1) BG107679A (fr)
BR (1) BR0114308A (fr)
CA (1) CA2423975A1 (fr)
CZ (1) CZ302181B6 (fr)
DZ (1) DZ3480A1 (fr)
EA (1) EA005109B1 (fr)
EC (1) ECSP034528A (fr)
GB (1) GB0023971D0 (fr)
HU (1) HUP0301188A3 (fr)
IL (2) IL155051A0 (fr)
MA (1) MA25912A1 (fr)
MX (1) MXPA03002868A (fr)
NO (2) NO20031435L (fr)
NZ (1) NZ524933A (fr)
OA (1) OA12399A (fr)
PL (1) PL363701A1 (fr)
SK (1) SK3782003A3 (fr)
UA (1) UA74842C2 (fr)
WO (1) WO2002026735A1 (fr)
ZA (1) ZA200302439B (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8133637B2 (en) * 2005-10-06 2012-03-13 Headwaters Technology Innovation, Llc Fuel cells and fuel cell catalysts incorporating a nanoring support
US7435741B2 (en) * 2006-05-09 2008-10-14 Teva Pharmaceutical Industries, Ltd. 2-N{5-[[4-[2-(methyl-2-pyridinylamino) ethoxy] phenyl]methyl]-2,4-thiazolidinedione} butanedioic acid, methods of preparation and compositions with rosiglitazone maleate
RU2570424C2 (ru) * 2009-12-15 2015-12-10 МЕТАБОЛИК СОЛЮШНЗ ДЕВЕЛОПМЕНТ КОМПАНИ, ЭлЭлСи Рапп-поддерживающие тиазолидиндионы и их комбинации для лечения нейродегенеративных заболеваний

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3856378T2 (de) * 1987-09-04 2000-05-11 Beecham Group Plc Substituierte Thiazolidindionderivate
GB9124513D0 (en) * 1991-11-19 1992-01-08 Smithkline Beecham Plc Novel process
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds
GB9308487D0 (en) * 1993-04-23 1993-06-09 Smithkline Beecham Plc Novel compounds
GB9723295D0 (en) * 1997-11-04 1998-01-07 Smithkline Beecham Plc Novel process
CN1253236A (zh) * 1998-11-11 2000-05-17 李扬远 一种以重力差释放引力能的方法
CN1183130C (zh) * 1999-09-24 2005-01-05 中国人民解放军军事医学科学院毒物药物研究所 噻唑烷类衍生物及其医药用途
HU225919B1 (en) * 1999-12-18 2007-12-28 Richter Gedeon Nyrt Thiazolidine-derivatives, process for their preparation pharmaceutical and intermediates
GB0006133D0 (en) * 2000-03-14 2000-05-03 Smithkline Beecham Plc Novel pharmaceutical

Also Published As

Publication number Publication date
AP1738A (en) 2007-05-07
CN1915992B (zh) 2010-05-12
CN101125852A (zh) 2008-02-20
DZ3480A1 (fr) 2002-04-04
KR20030039377A (ko) 2003-05-17
NO20031435D0 (no) 2003-03-28
AU2001292028B2 (en) 2005-04-21
MXPA03002868A (es) 2004-12-06
EP1813612A1 (fr) 2007-08-01
AU9202801A (en) 2002-04-08
CN101125853A (zh) 2008-02-20
BR0114308A (pt) 2003-10-14
GB0023971D0 (en) 2000-11-15
EA200300422A1 (ru) 2003-08-28
CA2423975A1 (fr) 2002-04-04
CN1466585A (zh) 2004-01-07
US20040214866A1 (en) 2004-10-28
US20040014752A1 (en) 2004-01-22
US20060004058A1 (en) 2006-01-05
NO20031435L (no) 2003-05-27
KR100917953B1 (ko) 2009-09-21
SK3782003A3 (en) 2004-06-08
US20050277679A9 (en) 2005-12-15
CZ302181B6 (cs) 2010-12-01
MA25912A1 (fr) 2003-10-01
HUP0301188A2 (hu) 2003-11-28
EP1332142A1 (fr) 2003-08-06
IL188116A0 (en) 2008-03-20
US20070185167A1 (en) 2007-08-09
AP2003002767A0 (en) 2003-03-31
NO20076517L (no) 2003-04-29
CN1915992A (zh) 2007-02-21
UA74842C2 (en) 2006-02-15
HUP0301188A3 (en) 2005-04-28
IL155051A0 (en) 2003-10-31
ECSP034528A (es) 2003-05-26
NZ524933A (en) 2004-12-24
CZ2003850A3 (cs) 2004-03-17
PL363701A1 (en) 2004-11-29
WO2002026735A1 (fr) 2002-04-04
ZA200302439B (en) 2004-04-28
EA005109B1 (ru) 2004-10-28
CN100345846C (zh) 2007-10-31
JP2004509959A (ja) 2004-04-02
BG107679A (bg) 2003-12-31

Similar Documents

Publication Publication Date Title
US20070185167A1 (en) Sodium salts of 5-[4-[2-(n-methyl-n-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione
US20040048899A1 (en) Tartrate salts of thiazollidnedione derivative
EP1315721B1 (fr) Derive de thiazolidinedione et son utilisation comme antidiabetique
EP1305311B1 (fr) Tartrate de derive de thiazolidinedione
WO2003050113A1 (fr) Sel d'hydrogene sulfate de 5-[4-[2-(n-methyl-n-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione
OA12355A (en) Tartrate salts of thiazolidinedione derivative.
EP1325000B1 (fr) Derive de thiazolidinedione et son utilisation comme anti-diabetique
AU2001292028A1 (en) Sodium salts of 5-'4-'2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl] thiazolidine-2,4-dione
EP1448559B1 (fr) 5-(4-(2-(n-methyl-n-(2-pyridil)amino)ethoxy)benzyl)thiazolidine-2,4-dione benzenesulfonate, procede de preparation, polymorphes i, ii et iii de celui-ci et son utilisation comme ingredient actif
US20040102485A1 (en) Tartrate salt of thiazolidinedione derivative
WO2003050111A1 (fr) Sels de type toluenesulfonate issus d'un derive de la thiazolidinedione
WO2003053963A1 (fr) Nouveau produit pharmaceutique
WO2003053964A1 (fr) Sel de 2-naphtalenesulfonate 5-(4-(2-(n-methyl-n-(2-pyridil)amino)ethoxy)benzyl)thiazolidine-2, 4-dione et son utilisation contre le diabete sucre
AU2001292034A1 (en) A thiazolidinedione derivative and its use as antidiabetic
WO2003050112A1 (fr) Hydrates de toluenesulfonate d'un derive de thiazolidinedione
WO2003050114A1 (fr) Sel de sulfate d'un derive de thiazolidinedione